France

France Biotech was founded in 1997 as an independent association, uniting the country’s leading innovative health companies and their expert partners. As a key facilitator of the health innovation ecosystem and a privileged point-of-contact for public authorities in France and Europe, France Biotech helps address the major challenges facing the HealthTech sector (including company financing, taxation, regulatory and market access issues, etc.). Its committees and working groups strive to identify viable solutions to create the necessary conditions for a competitive and attractive industry. Its objective is to support HealthTech startups and SMEs in becoming successful international companies capable of designing and developing innovative products and solutions rapidly and ultimately making them accessible to patients. France Biotech is the French equivalent of the US BIO (Biotechnology Innovation Organization). Lyonbiopôle is the health innovation cluster of the Auvergne-Rhône-Alpes region. It connects and supports industrial companies, SMEs, academic institutions, and healthcare stakeholders in the development of innovative solutions in biotech, medtech, and digital health. As a member of the national alliance of health clusters, Enosis Santé, Lyonbiopôle gives you access to some of the most dynamic health ecosystems and networks in France. Whether you work in oncology, neurology, or infectious diseases, or whether you are developing or manufacturing an ATMP, France offers high-level networks to help accelerate your innovation.